[1] EASTMAN BL. XII. Two Cases of Bone-Grafting for Cranial Defect. Ann Surg. 1895; 22(6):787-791.
[2] GALLARDO-CALERO I, BARRERA-OCHOA S, MANZANARES MC, et al. Vascularized Periosteal Flaps Accelerate Osteointegration and Revascularization of Allografts in Rats. Clin Orthop Relat Res. 2019;477(4):741-755.
[3] WANG H, FU X, SHI J, et al. Nutrient Element Decorated Polyetheretherketone Implants Steer Mitochondrial Dynamics for Boosted Diabetic Osseointegration. Adv Sci (Weinh). 2021;8(20):e2101778.
[4] MIGLIORINI F, LA PADULA G, TORSIELLO E, et al. Strategies for large bone defect reconstruction after trauma, infections or tumour excision: a comprehensive review of the literature. Eur J Med Res. 2021;26(1):118.
[5] FREEMAN E, TURNBULL RS. The value of osseous coagulum as a graft material. J Periodontal Res. 1973;8(4):229-236.
[6] CUTTING CB, MCCARTHY JG, BERENSTEIN A. Blood supply of the upper craniofacial skeleton: the search for composite calvarial bone flaps. Plast Reconstr Surg. 1984;74(5):603-610.
[7] RYU DJ, JUNG EY, HONG DH, et al. Efficacy of bone formation of microporous sphere-shaped biphasic calcium phosphate in a rabbit skull bone defect model. J Biomed Mater Res B Appl Biomater. 2021;109(2):294-307.
[8] OKUMUS A, GUVEN E, ERMIS I, et al. Comparative Analysis of Using Bone Graft, Hydroxyapatite Coralline (Biocoral®) and Porous Polyethylene (Medpor®) Implants for Cranioplasty in a Rat Model of Cranial Bone Defect. Turk Neurosurg. 2020;30(2):263-270.
[9] HILTUNEN A, VUORIO E, ARO HT. A standardized experimental fracture in the mouse tibia. J Orthop Res. 1993;11(2):305-312.
[10] HOLSTEIN JH, GARCIA P, HISTING T, et al. Advances in the establishment of defined mouse models for the study of fracture healing and bone regeneration. J Orthop Trauma. 2009;23(5 Suppl):S31-S38.
[11] WANG H, FU X, SHI J, et al. Nutrient Element Decorated Polyetheretherketone Implants Steer Mitochondrial Dynamics for Boosted Diabetic Osseointegration. Adv Sci (Weinh). 2021;8(20):e2101778.
[12] GHAMOR-AMEGAVI EP, YANG X, QIU J, et al. Composition control in biphasic silicate microspheres on stimulating new bone regeneration and repair of osteoporotic femoral bone defect. J Biomed Mater Res B Appl Biomater. 2020; 108(2):377-390.
[13] AKYOL U, GÜNGÖRMÜŞ M. Er:YAG laser ablation of bone in experimental diabetics. Photomed Laser Surg. 2010;28(4):477-482.
[14] PEARSON HB, MASON DE, KEGELMAN CD, et al. Effects of Bone Morphogenetic Protein-2 on Neovascularization During Large Bone Defect Regeneration. Tissue Eng Part A. 2019;25(23-24):1623-1634.
[15] KLEIN A, BARANOWSKI A, RITZ U, et al. Effect of bone sialoprotein coating on progression of bone formation in a femoral defect model in rats. Eur J Trauma Emerg Surg. 2020;46(2):277-286.
[16] KUMAWAT VS, BANDYOPADHYAY-GHOSH S, GHOSH SB. An overview of translational research in bone graft biomaterials. J Biomater Sci Polym Ed. 2022; 29:1-44.
[17] MARYCZ K, ŚMIESZEK A, KORNICKA-GARBOWSKA K, et al. Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of Osteoporotic Bone in Bilateral Cranial Defects in a Senescence-Accelerated Mouse Model (SAM/P6). PART 2. Int J Nanomedicine. 2021;16:6049-6065.
[18] SHUAI C, YU L, FENG P, et al. Interfacial reinforcement in bioceramic/biopolymer composite bone scaffold: The role of coupling agent. Colloids Surf B Biointerfaces. 2020;193:111083.
[19] LIU H, LIU S, JI H, et al. An adiponectin receptor agonist promote osteogenesis via regulating bone-fat balance. Cell Prolif. 2021;54(6):e13035.
[20] ANDREASEN CM, DING M, ANDERSEN TL, et al.Effects of substitute coated with hyaluronic acid or poly-lactic acid on implant fixation: Experimental study in ovariectomized and glucocorticoid-treated sheep. J Tissue Eng Regen Med. 2018;12(2):e1122-e1130.
[21] OMAR O, DAHLIN A, GASSER A, et al. Tissue dynamics and regenerative outcome in two resorbable non-cross-linked collagen membranes for guided bone regeneration: A preclinical molecular and histological study in vivo. Clin Oral Implants Res. 2018;29(1):7-19.
[22] LOVATI AB, LOPA S, RECORDATI C, et al. In Vivo Bone Formation Within Engineered Hydroxyapatite Scaffolds in a Sheep Model. Calcif Tissue Int. 2016;99(2):209-223.
[23] PRIETO EM, TALLEY AD, GOULD NR, et al. Effects of particle size and porosity on in vivo remodeling of settable allograft bone/polymer composites. J Biomed Mater Res B Appl Biomater. 2015;103(8):1641-1651.
[24] POBLOTH AM, JOHNSON KA, SCHELL H, et al. Establishment of a preclinical ovine screening model for the investigation of bone tissue engineering strategies in cancellous and cortical bone defects. BMC Musculoskelet Disord. 2016;17:111.
[25] ZHANG Y, WEI L, MIRON RJ, et al. Bone scaffolds loaded with siRNA-Semaphorin4d for the treatment of osteoporosis related bone defects. Sci Rep. 2016;6:26925.
[26] CAMARGO AF, BAPTISTA AM, NATALINO R, et al. Bioactive glass in cavitary bone defects: a comparative experimental study in rabbits. Acta Ortop Bras. 2015; 23(4):202-207.
[27] VEGGER JB, BRÜEL A, SØRENSEN TG, et al. Systemic Treatment with Strontium Ranelate Does Not Influence the Healing of Femoral Mid-shaft Defects in Rats. Calcif Tissue Int. 2016;98(2):206-214.
[28] ACKERSON RM, SHUM LC, BERRY AR, et al. In vivo model to measure bone repair efficacy of nanoparticle-based drug delivery. Orthopedics. 2014;37(8):e707-e711.
[29] ROSSELLI JE, MARTINS DM, MARTINS JL, et al. The effect of simvastatin on the regeneration of surgical cavities in the femurs of rabbits. Acta Cir Bras. 2014; 29(2):87-92.
[30] TAYTON E, PURCELL M, SMITH JO, et al. The scale-up of a tissue engineered porous hydroxyapatite polymer composite scaffold for use in bone repair: an ovine femoral condyle defect study. J Biomed Mater Res A. 2015;103(4):1346-1356.
[31] ALT V, THORMANN U, RAY S, et al. A new metaphyseal bone defect model in osteoporotic rats to study biomaterials for the enhancement of bone healing in osteoporotic fractures. Acta Biomater. 2013;9(6):7035-7042.
[32] GEMALMAZ HC, BOLUKBASI S, ESEN E, et al. Periosteal adventitia is a valuable bone graft alternative. Int J Artif Organs. 2013;36(5):341-349.
[33] KIM J, MCBRIDE S, TELLIS B, et al. Rapid-prototyped PLGA/β-TCP/hydroxyapatite nanocomposite scaffolds in a rabbit femoral defect model. Biofabrication. 2012; 4(2):025003.
[34] RÉ POPPI R, DA SILVA AL, NACER RS, et al. Evaluation of the osteogenic effect of low-level laser therapy (808 nm and 660 nm) on bone defects induced in the femurs of female rats submitted to ovariectomy. Lasers Med Sci. 2011;26(4): 515-522.
[35] COTTRELL JA, VALES FM, SCHACHTER D, et al. Osteogenic activity of locally applied small molecule drugs in a rat femur defect model. J Biomed Biotechnol. 2010;2010:597641.
[36] AIKAWA T, MATSUBARA H, UGAJI S, et al. Contribution of methylglyoxal to delayed healing of bone injury in diabetes. Mol Med Rep. 2017;16(1):403-409.
[37] HAJIALIZADE M, MOGHTADAEI M, MIRZAEI A, et al. Significant effect of simvastatin and/or ezetimibe-loaded nanofibers on the healing of femoral defect: An experimental study. Mater Sci Eng C Mater Biol Appl. 2020;111:110861.
[38] KERZNER B, MARTIN HL, WEISER M, et al. A Reliable and Reproducible Critical-Sized Segmental Femoral Defect Model in Rats Stabilized with a Custom External Fixator. J Vis Exp. 2019;(145):10.3791/59206.
[39] ALLURI R, SONG X, BOUGIOUKLI S, et al. Regional gene therapy with 3D printed scaffolds to heal critical sized bone defects in a rat model. J Biomed Mater Res A. 2019;107(10):2174-2182.
[40] CHENG P, LI D, GAO Y, et al. Prevascularization promotes endogenous cell-mediated angiogenesis by upregulating the expression of fibrinogen and connective tissue growth factor in tissue-engineered bone grafts. Stem Cell Res Ther. 2018;9(1):176.
[41] KRISHNAN L, PRIDDY LB, ESANCY C, et al. Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft. Clin Orthop Relat Res. 2015;473(9):2885-2897.
[42] PICKE AK, GORDALIZA ALAGUERO I, CAMPBELL GM, et al. Bone defect regeneration and cortical bone parameters of type 2 diabetic rats are improved by insulin therapy. Bone. 2016;82:108-115.
[43] ZWINGENBERGER S, NIEDERLOHMANN E, VATER C, et al. Establishment of a femoral critical-size bone defect model in immunodeficient mice. J Surg Res. 2013;181(1):e7-e14.
[44] CHAUBEY A, GRAWE B, MEGANCK JA, et al. Structural and biomechanical responses of osseous healing: a novel murine nonunion model. J Orthop Traumatol. 2013;14(4):247-257.
[45] ZARA JN, SIU RK, ZHANG X, et al. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A. 2011;17(9-10):1389-1399.
[46] BINSALAH MA, RAMALINGAM S, ALKINDI M, et al. Guided Bone Regeneration of Femoral Segmental Defects using Equine Bone Graft: An In-Vivo Micro-Computed Tomographic Study in Rats. J Invest Surg. 2019;32(5):456-466.
[47] HETTWER W, HORSTMANN PF, BISCHOFF S, et al. Establishment and effects of allograft and synthetic bone graft substitute treatment of a critical size metaphyseal bone defect model in the sheep femur. APMIS. 2019;127(2):53-63.
[48] CHU W, GAN Y, ZHUANG Y, et al. Mesenchymal stem cells and porous β-tricalcium phosphate composites prepared through stem cell screen-enrich-combine(-biomaterials) circulating system for the repair of critical size bone defects in goat tibia. Stem Cell Res Ther. 2018;9(1):157.
[49] MCGOVERN JA, GRIFFIN M, HUTMACHER DW. Animal models for bone tissue engineering and modelling disease. Dis Model Mech. 2018;11(4):dmm033084.
[50] SAMADIAN H, MOBASHERI H, AZAMI M, et al. Osteoconductive and electroactive carbon nanofibers/hydroxyapatite nanocomposite tailored for bone tissue engineering: in vitro and in vivo studies. Sci Rep. 2020;10(1):14853.
[51] SCHALLER B, MATTHIAS BURKHARD JP, CHAGNON M, et al. Fracture Healing and Bone Remodeling With Human Standard-Sized Magnesium Versus Polylactide-Co-Glycolide Plate and Screw Systems Using a Mini-Swine Craniomaxillofacial Osteotomy Fixation Model. J Oral Maxillofac Surg. 2018;76(10):2138-2150.
[52] BIGHAM-SADEGH A, ORYAN A. Selection of animal models for pre-clinical strategies in evaluating the fracture healing, bone graft substitutes and bone tissue regeneration and engineering. Connect Tissue Res. 2015;56(3):175-194.
[53] SCHMITZ JP, HOLLINGER JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res. 1986;(205):299-308.
[54] HOLLINGER JO, KLEINSCHMIDT JC. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg. 1990;1(1):60-68.
[55] TÖLLI H, KUJALA S, JÄMSÄ T, et al. Reindeer bone extract can heal the critical-size rat femur defect. Int Orthop. 2011;35(4):615-622.
[56] SKALICZKI G, SCHANDL K, WESZL M, et al. Serum albumin enhances bone healing in a nonunion femoral defect model in rats: a computer tomography micromorphometry study. Int Orthop. 2013;37(4):741-745.
[57] TAZAWA R, UCHIDA K, MINEHARA H, et al. Poly(POG)n loaded with recombinant human bone morphogenetic protein-2 accelerates new bone formation in a critical-sized bone defect mouse model. J Orthop Surg Res. 2020;15(1):471.
[58] ALAEE F, SUGIYAMA O, VIRK MS, et al. Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair. Gene Ther. 2014;21(2):139-147.
[59] 靳慧勇,侯天勇,罗飞,等.小鼠股骨临界骨缺损模型的构建及评估[J].第三军医大学学报,2011,33(22):2331-2334.
[60] LIU J, MAO K, LIU Z, et al. Injectable biocomposites for bone healing in rabbit femoral condyle defects. PLoS One. 2013;8(10):e75668.
[61] 徐石庄,王进,潘文振,等.兔股骨髁临界性骨缺损动物模型制备及临界骨缺损值[J].中国组织工程研究,2020,24(20):3191-3195.
[62] KIRBY GTS, WHITE LJ, STECK R, et al. Microparticles for Sustained Growth Factor Delivery in the Regeneration of Critically-Sized Segmental Tibial Bone Defects. Materials (Basel). 2016;9(4):259.
[63] ABO SHARKH H, MAKHOUL N. In-House Surgeon-Led Virtual Surgical Planning for Maxillofacial Reconstruction. J Oral Maxillofac Surg. 2020;78(4):651-660.
[64] STAMM T, BÖTTCHER D, KLEINHEINZ J. The University Münster model surgery system for orthognathic surgery - The digital update. Head Face Med. 2021; 17(1):31.
[65] SINGH GD, SINGH M. Virtual Surgical Planning: Modeling from the Present to the Future. J Clin Med. 2021;10(23):5655.
[66] LOHRE R, WARNER JJP, ATHWAL GS, et al. The evolution of virtual reality in shoulder and elbow surgery. JSES Int. 2020;4(2):215-223.
[67] SUN Y, HELMHOLZ H, WILLUMEIT-RÖMER R. Surgical Classification for Preclinical Rat Femoral Bone Defect Model: Standardization Based on Systematic Review, Anatomical Analysis and Virtual Surgery. Bioengineering (Basel). 2022;9(9):476.
[68] KIM JE, SONG DH, KIM SH, et al. Development and characterization of various osteoarthritis models for tissue engineering. PLoS One. 2018;13(3):e0194288.
[69] BADWELAN M, ALKINDI M, RAMALINGAM S, et al. The Efficacy of Recombinant Platelet-Derived Growth Factor on Beta-Tricalcium Phosphate to Regenerate Femoral Critical Sized Segmental Defects: Longitudinal In Vivo Micro-CT Study in a Rat Model. J Invest Surg. 2020;33(5):476-488.
[70] PAN Z, JIANG P, XUE S, et al. Repair of a critical-size segmental rabbit femur defect using bioglass-β-TCP monoblock, a vascularized periosteal flap and BMP-2. J Biomed Mater Res B Appl Biomater. 2018;106(6):2148-2156.
[71] KUROIWA Y, NIIKURA T, LEE SY, et al. Escherichia coli-derived BMP-2-absorbed β-TCP granules induce bone regeneration in rabbit critical-sized femoral segmental defects. Int Orthop. 2019;43(5):1247-1253.
[72] HORNER EA, KIRKHAM J, WOOD D, et al. Long bone defect models for tissue engineering applications: criteria for choice. Tissue Eng Part B Rev. 2010;16(2): 263-271.
[73] GARSKE DS, SCHMIDT-BLEEK K, ELLINGHAUS A, et al. Alginate Hydrogels for In Vivo Bone Regeneration: The Immune Competence of the Animal Model Matters. Tissue Eng Part A. 2020;26(15-16):852-862.
[74] KRAUS T, FISCHERAUER S, TREICHLER S, et al. The influence of biodegradable magnesium implants on the growth plate. Acta Biomater. 2018;66:109-117.
[75] JEWELL E, RYTLEWSKI J, ANGLE JO, et al. Surgical Fixation Hardware for Regeneration of Long Bone Segmental Defects: Translating Large Animal Model and Human Experiences. Clin Rev Bone Miner Metab. 2015;13(4). doi: 10.1007/s12018-015-9195-8
[76] HERTEN M, ZILKENS C, THOREY F, et al. Biomechanical Stability and Osteogenesis in a Tibial Bone Defect Treated by Autologous Ovine Cord Blood Cells-A Pilot Study. Molecules. 2019;24(2):295.
[77] PATEL PP, BUCKLEY C, TAYLOR BL, et al. Mechanical and biological evaluation of a hydroxyapatite-reinforced scaffold for bone regeneration. J Biomed Mater Res A. 2019;107(4):732-741.
[78] ZHA Y, LI Y, LIN T, et al. Progenitor cell-derived exosomes endowed with VEGF plasmids enhance osteogenic induction and vascular remodeling in large segmental bone defects. Theranostics. 2021;11(1):397-409.
[79] MABILLEAU G, MIECZKOWSKA A, LIBOUBAN H, et al. Comparison between quantitative X-ray imaging, dual energy X-ray absorptiometry and microCT in the assessment of bone mineral density in disuse-induced bone loss. J Musculoskelet Neuronal Interact. 2015;15(1):42-52.
[80] CLARK DP, BADEA CT. Advances in micro-CT imaging of small animals. Phys Med. 2021;88:175-192.
[81] NEGRI AL, DEL VALLE EE, ZANCHETTA MB, et al. Evaluation of bone microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT) in hemodialysis patients. Osteoporos Int. 2012;23(10): 2543-2550.
[82] PERMUY M, GUEDE D, LÓPEZ-PEÑA M, et al. Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits. BMC Musculoskelet Disord. 2015;16:120.
[83] WU Y, ADEEB S, DOSCHAK MR. Using Micro-CT Derived Bone Microarchitecture to Analyze Bone Stiffness - A Case Study on Osteoporosis Rat Bone. Front Endocrinol (Lausanne). 2015;6:80.
[84] ALBERT CI, JAMESON J, HARRIS G. Design and validation of bending test method for characterization of miniature pediatric cortical bone specimens. Proc Inst Mech Eng H. 2013;227(2):105-113.
[85] SCHWIEDRZIK J, RAGHAVAN R, BÜRKI A, et al. In situ micropillar compression reveals superior strength and ductility but an absence of damage in lamellar bone. Nat Mater. 2014;13(7):740-747.
[86] KIM HK, PARK KS, LEE JS, et al. Salicylideneamino-2-thiophenol enhances osteogenic differentiation through the activation of MAPK pathways in multipotent bone marrow stem cell. J Cell Biochem. 2012;113(6):1833-1841.
[87] GASIŃSKA T, BOROWSKA A, WICHARY H, et al. Effect of methylprednisolone pulse therapy with and without alendronate on biochemical markers of bone turnover in patients with Graves’ ophthalmopathy. Pol Arch Med Wewn. 2012;122(7-8): 341-347.
[88] BIGUETTI CC, COUTO MCR, SILVA ACR, et al. New Surgical Model for Bone-Muscle Injury Reveals Age and Gender-Related Healing Patterns in the 5 Lipoxygenase (5LO) Knockout Mouse. Front Endocrinol (Lausanne). 2020;11:484.
[89] MCCABE IC, FEDORKO A, MYERS MG JR,et al. Novel leptin receptor signaling mutants identify location and sex-dependent modulation of bone density, adiposity, and growth. J Cell Biochem. 2019;120(3):4398-4408. |